Lisata Therapeutics, Inc. (LSTA) Ownership

$2.52

south_east
-$0.03 (-1.18%)
Day's range
$2.39
Day's range
$2.57

Lisata Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 270.51 K $708.75 K   6.43% 3.14%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 116.62 K $305.55 K   13.42% 1.36%
BML CAPITAL MANAGEMENT, LLC 11/10/2025 109.84 K $287.78 K   -47.65% 1.28%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 63.26 K $165.78 K   3.57% 0.74%
BLACKROCK, INC. 11/12/2025 54.89 K $143.81 K   0.06% 0.64%
GROUND SWELL CAPITAL, LLC 11/06/2025 23.77 K $62.29 K   100.00% 0.28%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 20.95 K $54.88 K   -18.79% 0.24%
STATE STREET CORP 11/14/2025 14.35 K $37.59 K   0.00% 0.17%
11/12/2025 13.98 K $36.63 K   100.00% 0.16%
CERITY PARTNERS LLC 10/22/2025 12.18 K $30.70 K   0.00% 0.14%
XTX TOPCO LTD 11/14/2025 11.11 K $29.11 K   100.00% 0.13%
BANK OF AMERICA CORP /DE/ 11/14/2025 10.42 K $27.29 K   -0.04% 0.12%
NORTHERN TRUST CORP 11/14/2025 10.27 K $26.90 K   0.00% 0.12%
HIGHTOWER ADVISORS, LLC 11/07/2025 10.04 K $26.31 K   0.00% 0.12%
ROYAL BANK OF CANADA 11/14/2025 5.91 K $15.00 K   0.00% 0.07%
FOUNDERS CAPITAL MANAGEMENT 11/13/2025 2.00 K $5.24 K   0.00% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 1.67 K $4.38 K   26.30% 0.02%
CONNECTIVE CAPITAL MANAGEMENT, LLC 11/17/2025 1.02 K $2.66 K   100.00% 0.01%
MORGAN STANLEY 11/14/2025 208 $545   -7.14% 0.00%
SBI SECURITIES CO., LTD. 11/05/2025 140 $367   0.00% 0.00%
BARCLAYS PLC 11/12/2025 4 $10   100.00% 0.00%
CHEVIOT VALUE MANAGEMENT, LLC 10/31/2025 3 $8   0.00% 0.00%
RAYMOND JAMES FINANCIAL INC 11/14/2025 0 $0   -100.00% 0.00%
UBS GROUP AG 11/13/2025 0 $0   -100.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 0 $0   -100.00% 0.00%

Lisata Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 26 institutional investors and hedge funds held shares of Lisata Therapeutics, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 270,514

RENAISSANCE TECHNOLOGIES LLC: 116,622

BML Capital Management, LLC: 109,841

GEODE CAPITAL MANAGEMENT, LLC: 63,260

BlackRock, Inc.: 54,890

Ground Swell Capital, LLC: 23,774

8.75% of Lisata Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 807.36 K shares in the last 24 months. This purchase volume represents approximately $2.03 M in transactions.